白血球除去市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00005515
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 190
Buy Now

[調査レポート]白血球除去市場は、2021 年の 7,448 万米ドルから 2028 年までに 1 億 3,390 万米ドルに達すると予測されています。 2021 年から 2028 年までに 8.7% の CAGR で成長すると推定されています。



白血球除去は、体の免疫応答に関与する白血球 (白血球) を血液サンプルから分離する手順です。これは、赤血球や血小板などの血液成分を採取し、残りの血液を循環に戻すアフェレーシスの特殊な形式です。白血球除去療法は、慢性リンパ性白血病 (CLL) などの慢性血液がんなど、非常に高い白血球 (WBC) 数を減らすためによく使用されます。また、がん化学療法中の白血球数の急激な減少を管理するなど、後の移植用の白血球を取得するために行うこともできます。別の用途は、白血病、前立腺がん、および他の形態のがんとの闘いを助ける、キメラ抗原受容体 (CAR) T 細胞療法と呼ばれる新しい形態の免疫療法の一部として使用されます。白血球除去は、治療を希望する本人に対して行うこともできます(自己アフェレーシス)、または後の移植のためのドナーに対して行うこともできます(同種アフェレーシス)。現在、白血球除去療法はさまざまな病気の治療に一般的に使用されており、循環腫瘍細胞の収量を増加させることができるため、診断目的にも使用されています。自発的な献血者数の増加、血液疾患の発生率の増加、高齢者人口の急増などの要因が白血球除去市場の成長を促進しています。ただし、白血球除去の高コストは市場の成長をある程度妨げています。



白血球除去市場の有利な地域

市場洞察



輸血は、さまざまな国の国家医療インフラと政策の不可欠な部分です。医療業界の進歩により、重篤な病気や怪我の治療手順が改善され、最終的には患者への輸血の必要性が高まりました。生存。輸血の重要性と医療サービスにおける血液の利用可能性についての意識の高まりにより、医療目的のために献血を希望する人の数が増加しています。世界保健機関 (WHO) のデータによると、2018 年には世界中で約 1 億 1,740 万件の献血が報告されました。通常、献血者は自発的な無報酬、有償、家族/代替者に分類されますが、WHO の主張によれば、自発的/無給の献血者が分類されます。信頼性が高く適切な血液供給の主要な供給源です。 2019年のWHOのデータによると、自発的な無償献血者による献血は、2008年から2015年にかけて世界139カ国で1160万件増加した。献血の傾向は、低所得国および中所得国でも顕著になってきています。 2017年の全能神教会年次総会で発表されたデータによると、2016年には1,087人の患者に対して約13,000件の手術が行われた。自発的な献血者の数が最も急増したのは東南アジア諸国(83%)と南北アメリカ(70%)だった。 .



多くの国で開発され展開されている国家プログラムにより、さらに多くの血小板および献血者が集まります。たとえば、インドでは、国家エイズ対策機関 (NACO) 内に構成された国家輸血評議会 (NBTC) が、州エイズ対策協会 (SACS) 内に設立された州輸血評議会 (SBTC) と連携する中心機関です。 )。 NBTC は、輸血サービス (BTS) に関連するさまざまな活動の保健プログラムをサポートしています。したがって、世界中のさまざまな国で適格なドナーの数が増加しているため、必要な血液成分を分離するために使用される白血球除去装置の必要性が高まっています。



製品タイプベースの洞察



製品タイプに基づいて、白血球除去市場は白血球除去装置と白血球除去用使い捨て製品に二分されます。 2021 年には、白血球除去用使い捨て製品セグメントがより大きな市場シェアを保持しました。ただし、白血球除去装置セグメントは、2021 年から 2028 年にかけてより高い CAGR を記録すると予想されます。



製品タイプ別の白血球除去市場 - 2021 年および 2028 年

アプリケーションベースの洞察



白血球除去市場は、用途別に研究用途と治療用途に分かれています。 2021 年には、リサーチ アプリケーション セグメントが市場でより大きなシェアを占めており、同セグメントは今後数年間でより高い CAGR を記録すると予想されます。



エンドユーザーベースの洞察



白血球除去市場は、エンドユーザーごとに、製薬企業およびバイオテクノロジー企業、学術機関および研究機関、血液成分プロバイダーおよび血液センター、病院および輸血センターに分割されています。 2021年には、血液成分プロバイダーと血液センター部門が市場で最大のシェアを占めました。一方、病院および輸血センター部門は、今後数年間で最高の CAGR を記録すると予想されています。



戦略的洞察



白血球除去市場で事業を展開している企業は、次のような戦略を採用しています。製品の発売、合併と買収、コラボレーション、製品イノベーション、製品ポートフォリオの拡張などにより、世界中で事業展開を拡大し、ブランド名を維持し、エンドユーザーからの高まる需要に応えます。



白血球除去市場 – 製品タイプ別< /p>


  • 白血球除去装置

    • アフェレーシス装置

    • 白血球除去カラムおよび細胞分離器

    • 白血球除去フィルター


  • 白血球除去用ディスポーザブル


白血球除去市場 – 用途別





  • 研究用途

  • 治療用途

  • 白血球除去市場 - エンドユーザー別





    • 製薬会社およびバイオテクノロジー企業

    • 学術機関および研究機関

    • 血液成分プロバイダーおよび血液センター< /li>
    • 病院と輸血センター


    白血球除去市場 - 地理別





    • 北米

      • 米国

      • < li>カナダ
      • メキシコ



    • ヨーロッパ

      • フランス

      • ドイツ

      • イタリア

      • 英国

      • スペイン

      • ヨーロッパのその他の地域



    • アジア太平洋 (APAC)

        < li>中国
      • インド

      • 韓国

      • 日本

      • オーストラリア

      • その他のアジア太平洋地域

      • >


    • 中東およびアフリカ (MEA)

      • 南アフリカ

      • サウジアラビア

      • アラブ首長国連邦

      • 中東およびアフリカのその他の地域



    • 南アメリカ (SAM)

      • ブラジル

      • アルゼンチン

      • その他中南米




    会社概要





    • 旭化成株式会社

    • Fresenius SE & Co . KGaA

    • ヘモネティクス株式会社

    • テルモ株式会社

    • STEMCELL Technologies Inc.

    • HemaCare

    • マコファーマ

    • >
    • AllCells

    • STEMEXPRESS

    • BioIVT


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are leukapheresis?

Leukapheresis is a procedure that has white blood cells (leukocytes) involved in the body's immune response are segregated from a blood sample. It is a particular form of apheresis in which an element of blood, such as red blood cells or platelets, is obtained while the remaining blood is restored to circulation. Leukapheresis is often used to reduce very high white blood cell (WBC) counts, such as chronic blood cancers like chronic lymphocytic leukemia (CLL). It can also be completed to obtain white blood cells for later transplant, such as to manage abrupt declines in WBC counts throughout cancer chemotherapy. Another use is as a section of a novel form of immunotherapy, termed chimeric antigen receptor (CAR) T-cell therapy, to help fight leukemia, prostate cancer, and other forms of cancers. Leukapheresis can be completed on the person claiming treatment (autologous apheresis) or on a donor for a later transplant (allogeneic apheresis). Currently, leukapheresis is commonly used to treat various diseases, and it is also used for diagnostic purposes as it can increase circulating tumor cells yields.

What are the driving factors for the leukapheresis market across the globe?

Key factors that are driving the growth of this market are number of voluntary blood donors, increasing incidence of hematologic diseases, surge in elderly population and growing demand for leukopaks in clinical research activities boost the market growth over the years.

Which product type led the leukapheresis market?

The leukapheresis disposables segment dominated the global leukapheresis market and held the largest revenue share of 61.43% in 2021.

Which end-user held the largest share in the leukapheresis market?

The blood component providers and blood centers segment dominated the global leukapheresis market and accounted for the largest revenue share of 35.03% in 2021.

Who are the key players in the leukapheresis market?

The leukapheresis market majorly consists of the players such Asahi Kasei Corporation, Fresenius SE & Co. KGaA, Haemonetics Corporation Terumo Corporation, STEMCELL Technologies Inc., HemaCare, Macopharma, AllCells, STEMEXPRESS, and BioIVT amongst others.

What is the regional market scenario of leukapheresis?

Global leukapheresis market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for leukapheresis. The growth of the region is attributed to increasing product launches coupled with increasing patient population.
The Asia Pacific region is expected to account for the fastest growth in the leukapheresis market. Increase in government investments and a number of private biotechnology companies in this region contribute to this dominant share. The rising geriatric population and increasing investment in research are said to be responsible for this growth.

The List of Companies - Leukapheresis Market

  1. Asahi Kasei Corporation
  2. Fresenius SE & Co. KGaA
  3. Haemonetics Corporation
  4. Terumo Corporation
  5. STEMCELL Technologies Inc.
  6. HemaCare
  7. Macopharma
  8. AllCells
  9. STEMEXPRESS
  10. BioIVT

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports